Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study.
eHEALS
eHealth
mHealth
mobile applications
rheumatology
telemedicine
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
12 08 2020
12 08 2020
Historique:
received:
28
04
2020
accepted:
25
06
2020
revised:
25
05
2020
pubmed:
18
7
2020
medline:
18
3
2021
entrez:
18
7
2020
Statut:
epublish
Résumé
Mobile health (mHealth) defines the support and practice of health care using mobile devices and promises to improve the current treatment situation of patients with chronic diseases. Little is known about mHealth usage and digital preferences of patients with chronic rheumatic diseases. The aim of the study was to explore mHealth usage, preferences, barriers, and eHealth literacy reported by German patients with rheumatic diseases. Between December 2018 and January 2019, patients (recruited consecutively) with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis were asked to complete a paper-based survey. The survey included questions on sociodemographics, health characteristics, mHealth usage, eHealth literacy using eHealth Literacy Scale (eHEALS), and communication and information preferences. Of the patients (N=193) who completed the survey, 176 patients (91.2%) regularly used a smartphone, and 89 patients (46.1%) regularly used social media. Patients (132/193, 68.4%) believed that using medical apps could be beneficial for their own health. Out of 193 patients, only 8 (4.1%) were currently using medical apps, and only 22 patients (11.4%) stated that they knew useful rheumatology websites/mobile apps. Nearly all patients (188/193, 97.4%) would agree to share their mobile app data for research purposes. Out of 193 patients, 129 (66.8%) would regularly enter data using an app, and 146 patients (75.6%) would welcome official mobile app recommendations from the national rheumatology society. The preferred duration for data entry was not more than 15 minutes (110/193, 57.0%), and the preferred frequency was weekly (59/193, 30.6%). Medication information was the most desired app feature (150/193, 77.7%). Internet was the most frequently utilized source of information (144/193, 74.6%). The mean eHealth literacy was low (26.3/40) and was positively correlated with younger age, app use, belief in benefit of using medical apps, and current internet use to obtain health information. Patients with rheumatic diseases are very eager to use mHealth technologies to better understand their chronic diseases. This open-mindedness is counterbalanced by low mHealth usage and competency. Personalized mHealth solutions and clear implementation recommendations are needed to realize the full potential of mHealth in rheumatology.
Sections du résumé
BACKGROUND
Mobile health (mHealth) defines the support and practice of health care using mobile devices and promises to improve the current treatment situation of patients with chronic diseases. Little is known about mHealth usage and digital preferences of patients with chronic rheumatic diseases.
OBJECTIVE
The aim of the study was to explore mHealth usage, preferences, barriers, and eHealth literacy reported by German patients with rheumatic diseases.
METHODS
Between December 2018 and January 2019, patients (recruited consecutively) with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis were asked to complete a paper-based survey. The survey included questions on sociodemographics, health characteristics, mHealth usage, eHealth literacy using eHealth Literacy Scale (eHEALS), and communication and information preferences.
RESULTS
Of the patients (N=193) who completed the survey, 176 patients (91.2%) regularly used a smartphone, and 89 patients (46.1%) regularly used social media. Patients (132/193, 68.4%) believed that using medical apps could be beneficial for their own health. Out of 193 patients, only 8 (4.1%) were currently using medical apps, and only 22 patients (11.4%) stated that they knew useful rheumatology websites/mobile apps. Nearly all patients (188/193, 97.4%) would agree to share their mobile app data for research purposes. Out of 193 patients, 129 (66.8%) would regularly enter data using an app, and 146 patients (75.6%) would welcome official mobile app recommendations from the national rheumatology society. The preferred duration for data entry was not more than 15 minutes (110/193, 57.0%), and the preferred frequency was weekly (59/193, 30.6%). Medication information was the most desired app feature (150/193, 77.7%). Internet was the most frequently utilized source of information (144/193, 74.6%). The mean eHealth literacy was low (26.3/40) and was positively correlated with younger age, app use, belief in benefit of using medical apps, and current internet use to obtain health information.
CONCLUSIONS
Patients with rheumatic diseases are very eager to use mHealth technologies to better understand their chronic diseases. This open-mindedness is counterbalanced by low mHealth usage and competency. Personalized mHealth solutions and clear implementation recommendations are needed to realize the full potential of mHealth in rheumatology.
Identifiants
pubmed: 32678796
pii: v8i8e19661
doi: 10.2196/19661
pmc: PMC7450373
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e19661Informations de copyright
©Johannes Knitza, David Simon, Antonia Lambrecht, Christina Raab, Koray Tascilar, Melanie Hagen, Arnd Kleyer, Sara Bayat, Adrian Derungs, Oliver Amft, Georg Schett, Axel J Hueber. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 12.08.2020.
Références
Ann Rheum Dis. 2010 Nov;69(11):1990-5
pubmed: 20498203
J Clin Rheumatol. 2019 Dec 9;:
pubmed: 31834100
JMIR Mhealth Uhealth. 2019 May 29;7(5):e12542
pubmed: 31144672
Arthritis Rheum. 2006 Aug;54(8):2665-73
pubmed: 16871531
RMD Open. 2019 Sep 13;5(2):e001014
pubmed: 31565245
Z Rheumatol. 2019 Nov;78(9):839-846
pubmed: 30542914
JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e7
pubmed: 28223263
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
J Cancer Educ. 2015 Dec;30(4):685-92
pubmed: 25355524
J Med Internet Res. 2006 Nov 14;8(4):e27
pubmed: 17213046
JMIR Mhealth Uhealth. 2017 Jun 14;5(6):e81
pubmed: 28615159
JMIR Mhealth Uhealth. 2018 Oct 29;6(10):e12221
pubmed: 30373732
JMIR Mhealth Uhealth. 2019 Aug 05;7(8):e14991
pubmed: 31381501
Arthritis Care Res (Hoboken). 2019 Oct;71(10):1336-1343
pubmed: 30242992
JMIR Mhealth Uhealth. 2019 Aug 26;7(8):e14284
pubmed: 31452521
JMIR Hum Factors. 2017 Jan 27;4(1):e4
pubmed: 28130203
BMC Musculoskelet Disord. 2016 Aug 24;17(1):362
pubmed: 27553253
J Med Internet Res. 2006 Jun 16;8(2):e9
pubmed: 16867972
JMIR Res Protoc. 2018 Apr 11;7(4):e84
pubmed: 29643053
J Med Internet Res. 2019 Mar 14;21(3):e11276
pubmed: 30869642
JMIR Mhealth Uhealth. 2019 Jul 10;7(7):e13817
pubmed: 31293246
Patient Educ Couns. 2013 Jan;90(1):4-11
pubmed: 23063359
Ann Rheum Dis. 2009 Jun;68(6):770-6
pubmed: 19297345
J Med Internet Res. 2011 Nov 03;13(4):e90
pubmed: 22052161
JMIR Mhealth Uhealth. 2019 Nov 26;7(11):e14730
pubmed: 31769758
JMIR Mhealth Uhealth. 2019 Jun 3;7(6):e13199
pubmed: 31199343
JMIR Mhealth Uhealth. 2020 Apr 20;8(4):e14351
pubmed: 32310151
Clin Epidemiol. 2016 Oct 25;8:737-742
pubmed: 27822121
J Med Internet Res. 2012 Jan 27;14(1):e19
pubmed: 22357448
Reumatol Clin. 2019 Nov 10;:
pubmed: 31722849
Rheumatology (Oxford). 2011 Sep;50(9):1618-26
pubmed: 21551221
JMIR Mhealth Uhealth. 2016 Feb 02;4(1):e12
pubmed: 26839283
JMIR Mhealth Uhealth. 2019 Mar 28;7(3):e12179
pubmed: 30920383
J Med Internet Res. 2018 Apr 20;20(4):e138
pubmed: 29678800
Perspect Health Inf Manag. 2012;9:1-13
pubmed: 23209454
Rheumatology (Oxford). 2017 Oct 1;56(10):1707-1712
pubmed: 28957553
J Med Internet Res. 2013 Feb 11;15(2):e27
pubmed: 23399720
Rheumatol Int. 2018 Nov;38(11):1949-1957
pubmed: 29713795